[Federal Register Volume 62, Number 108 (Thursday, June 5, 1997)]
[Notices]
[Pages 30872-30873]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-14663]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Call for Nominations for the National
Cancer Institute Director's Consumer Liaison Group
The National Cancer Institute (NCI), the Federal Government's
primary agency for cancer research, is launching a new initiative--the
Director's Consumer Liaison Group (DCLG). Notice is hereby given that
the NCI is accepting nominations for membership on the DCLG. This group
will help the NCI to increase the representation of the cancer advocacy
community on Institute advisory committees, and increase their
involvement in program and policy development. The DCLG will consist of
fifteen (15) consumer-advocates who are involved in cancer advocacy.
The NCI will bring together these advocates from diverse communities,
creating a two-way street that enables them to interact directly with
the scientific community at the NCI on a wide range of programs and
issues. The DCLG will also help the NCI to widen the pool of qualified
consumer-advocates who can be called upon to serve on NCI advisory
committees and other groups. Specifically the DCLG will meet several
times a year to:
Help develop and establish processes, mechanisms, and
criteria for identifying appropriate consumer-advocates to serve on a
variety of program and policy advisory committees responsible for
advancing the mission of the NCI.
Serve as a primary forum for discussing issues and
concerns and exchanging viewpoints that are important to the broad
development of the NCI programmatic and research priorities.
Establish and maintain strong collaborations between the
NCI and the cancer advocacy community to reach common goals.
The DCLG will provide advice and make recommendations to the
Advisory Committee to the Director, NCI. Members of the first DCLG will
serve one, two, or three year terms. In subsequent years, members will
serve three year terms.
Eligibility Requirements for Individual Members. To serve on the
DCLG, a member must meet the following minimum eligibility
requirements:
Be involved in the cancer experience as a cancer survivor,
a person affected by the suffering and consequences of cancer, or a
professional or volunteer who works with survivors or those affected.
Represent a constituency (formally or informally) with
which she or he communicates regularly on cancer issues and be able to
serve as a conduit for information both to and from his/her
constituency.
Another essential requirement is a commitment to participating in
the DCLG. This will not be used in the initial screening of nominees,
but will be assessed as part of a more in-depth evaluation of qualified
candidates.
Criteria for Evaluating Individual Candidates. Nominees who meet
the minimum eligibility requirements will be further assessed based on
the following criteria:
Cancer advocacy experience.
Ability to communicate effectively.
Ability to represent broad issues, think ``globally.''
Ability to contribute to an effective group process (e.g.,
cooperative, constructive, flexible, innovative).
Leadership ability. (While members of the DCLG are not
required to hold a formal leadership position within a cancer advocacy
organization, they must have leadership skills.)
Characteristics of the DCLG. In addition to the criteria for
individual candidates, the following characteristics of the DCLG as a
group are intended to ensure that it reflects the breadth and diversity
of the consumer advocacy community:
Multicultural diversity.
A broad mix of cancer sites.
Representation of the medically underserved.
Men and women.
A range of organizations (local/regional and national).
Age diversity.
Geographic diversity (rural/urban mix).
[[Page 30873]]
Screening, Scoring, and Review Process. After nominees are screened
for eligibility, they will be scored in terms of the criteria. A list
of highly qualified candidates who reflect balance and diversity of
representation will be forwarded to the Director, NCI, for selection of
the DCLG members.
Nomination Process. The call for nominations is being disseminated
to a broad range of groups, including local, regional and national
organizations, to encourage nominations of candidates reflecting the
diversity sought for the DCLG. Nominations may come from members of
organizations, or individuals, including self-nominations. The
nominations must be postmarked by September 15, 1997. To request a
nomination package send your name, advocacy organization affiliation
(if any), and address to the Office of Liaison Activities, NCI, c/o
Palladian Partners, 7315 Wisconsin Avenue, Suite 440 W, Bethesda, MD
20814, FAX (301) 986-5047.
Dated: May 28, 1997.
Marvin Kalt,
Director, Division of Extramural Activities, National Cancer Institute.
[FR Doc. 97-14663 Filed 6-4-97; 8:45 am]
BILLING CODE 4140-01-M
